Today's Hours: 8:00am - 10:00pm

Search

Did You Mean:

Search Results

  • Book
    [edited by] Jeffrey S. Dover, Kavita Mariwalla.
    Summary: "Although board-certified dermatologists provide the best care for their patients, managing a practice and optimizing every facet of the business is a daunting endeavor. Business acumen is not taught in residency and is the most overlooked aspect of any given practice. The Business of Dermatology, written by esteemed dermatologists Jeffrey S. Dover, Kavita Mariwalla, and an impressive group of experts, provides a rare opportunity to learn about the operations side of practices across the country. Written in an informal tone, this unique book enables readers to be privy to a "40-way chat" with dermatologists whose practices are flourishing. With a vast wealth of information relevant to the business side of a dermatology practice, this remarkable resource fills the gap between the training phase and acquisition of professional confidence. Fiftyfive chapters offer insightful, highly practical pearls for everyone-from early-career dermatologists and those in solo-practice to employed physicians in large groups. Even the most seasoned practitioners will benefit from firsthand knowledge and real-world tips shared by physicians who have made their own mistakes trying to get practices off the ground and maintain them. The Business of Dermatology is an indispensable, one-stop source for all trainee and practicing dermatologists who need insightful guidance on setting up, organizing, managing, or optimizing their practice"-- Provided by publisher.
    Digital Access
    Provider
    Version
    Thieme MedOne Plastic Surgery
    Thieme-Connect
  • Article
    Odegård OR, Abildgaard U.
    Haemostasis. 1978;7(2-3):127-34.
    Thrombin or factor Xa added to plasma are inactivated by antithrombin III (At-III). The inactivation is accelerated by heparin, permitting assay systems which rapidly measure the At-III content of diluted plasma. Without heparin, the slow inactivation rates may be measured. Existing activity assays (fibrinogen or chromogenic substrates) and immunoassays of At-III have been reviewed. Correlation studies show a close correlation between the results of immunoassay and the results of most activity assays. In health, a narrow range of At-III has been found. The level is low in infancy. Fertile women have on the average somewhat lower levels than men. In old age, the level tends to drop. In clinical material studied with amidolytic assays, subnormal At-III levels were found in hereditary deficiency, liver disease, disseminated intravascular coagulation and in some cases with acute thrombosis. The amidolytic assays are rapid to perform, do not require experience in clotting technique and seem preferable in clinical routine work.
    Digital Access Access Options